Patient Education
New Targeted Pill Shows Promise for Advanced Pancreatic Cancer
A new targeted treatment for advanced pancreatic cancer has shown encouraging early results in a major clinical trial. The experimental pill, darax...
POLAR Trial Offers New Hope for Some Patients With Metastatic Pancreatic Cancer
Early findings from the Phase 2 POLAR trial suggest that combining pembrolizumab and olaparib may benefit selected patients with metastatic pancrea...
PICCOS Clinical Trial Explores Innovative Treatment for Peritoneal Cancer
The PICCOS clinical trial is exploring an innovative chemotherapy approach called PIPAC for people with peritoneal cancer. Researchers hope this ta...
When Life Suddenly Changes: A New Guide for Young Adults Facing Digestive Cancer
DiCE launches When Life Turns to the In-Between, a new patient-led booklet supporting young adults facing digestive cancers. Covering fertility, in...
Europe’s Beating Cancer Plan: The Real Failure Is Implementation
On 14 April 2026, MEP Vlad Voiculescu (Renew, Romania) presented his report on the implementation of Europe’s Beating Cancer Plan in the European...
Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment
Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...
Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention
A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...
When a Parent Has Cancer: How to Talk to Your Children, Honestly and Gently
Telling a child you have cancer is never easy. This practical guide helps families navigate the conversation with honesty, reassurance, and care—...
Patents, Prices, and Patients: a Global Campaign Putting Access to Medicines Under the Spotlight
New global campaign Patients and Patents highlights how pharmaceutical patent practices affect access to affordable medicines. With clear tools and...
A Turning Point Before Surgery: CASSANDRA Redefines Neoadjuvant Therapy in Pancreatic Cancer
The CASSANDRA phase III trial shows that the PAXG regimen significantly improves outcomes over mFOLFIRINOX in resectable pancreatic cancer. This pa...